Class IIITerminatedD-0006-2017
Drug recall · October 12, 2016
Vyvanse recall
Why: Presence of Foreign Tablets/Capsules
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10
- Lots / codes
Lot # AF3360B; Exp. 04/19
- Quantity
- 7,680 bottles (768,000 capsules)
- Company
- Shire, Chesterbrook, PA
- Distribution
- Nationwide
- Initiated
- September 2, 2016 · Voluntary: Firm initiated
- Classified
- October 5, 2016
- Reported
- October 12, 2016
- Ended
- March 8, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Vyvanse
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.